Delivery Order SPE2DB22D3501-SPE2DB25FTH03

Award Date 10/28/24
Potential Completion Date 11/19/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,989.53, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $8,989.53 with a completion date of December 27, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,996.51 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and a period of performance through December 18, 2024. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $53,458.36 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and has an ultimate completion date of July 23, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a fixed-price delivery order type with a ceiling value of $3,951.86 and a period of performance ending on June 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is not set aside and is open to full and open...
This federal contract award is for the pharmaceutical product SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,896.41, and has a period of performance through November 13, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $15,385.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialized pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $17,831.12, is for the delivery of Somatuline Depot 90 mg/0.3 ml medication. It is a firm fixed price, delivery order contract with an ultimate completion date of October 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award is for the delivery of Somatuline Depot 90 mg/0.3 mL 0.3mL medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $10,257.26 and was awarded on February 25, 2022 with a completion date of March 18, 2022. The contract type is a Delivery Order with Firm Fixed Pricing. There is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,903.74, is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a performance period through March 19, 2025. This award is not designated as a set-aside contract. AmerisourceBergen also holds a significant...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTH03
    Delivery Order

This federal contract award is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,228.89, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 1/27/25, 1:11 PM